Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old
Clinical trial NCT05249556 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05249556
- Sponsor
- Immedica Pharma AB
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2027-03-01
- Primary completion
- 2029-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.